KIR #13 – Designing a digital real-world study

KIR #13 – Designing a digital real-world study

On 25th January, we hosted the 13th webinar in the “Keeping it real” series. How to design a digital real-world study? Real-World Evidence Generation Approaches in rare disease and oncology. Mark Larkin PhD, Founder and CEO, and Dr Catherine Bottomley, Chief...
Reflecting on 2022, and looking into the (RWE) crystal ball…

Reflecting on 2022, and looking into the (RWE) crystal ball…

Future historians are likely to look back on 2022 as a year of political, economic, and climatic turbulence… as the year winds down, however, the team at Vitaccess are taking the opportunity to look back a little more fondly – at the past, present, and future of...
Join our ISPOR short course

Join our ISPOR short course

Join Dr Mark Larkin, Dr Catherine Bottomley, and Dr Casey Quinn for the virtual ISPOR short course on Digital Real-World Evidence Generation Approaches in Rare Diseases and Oncology. The course is designed to provide a good understanding of how to plan and undertake...
KIR#12 – Patient engagement and retention in real-world studies

KIR#12 – Patient engagement and retention in real-world studies

Sam Llewellyn, Senior Consultant, and Dr Mark Larkin, CEO and Founder of Vitaccess, presented examples of real-world studies where patient retention strategies have been used, resulting in strong engagement. Suitable for all evidence generation stakeholders, they...
Skip to content